A Multicenter Randomized Double Blind Placebo Controlled Parallel Group Pilot Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects with Relapsing-remitting Multiple Sclerosis

Study Overview

The purpose of this study is to examine the safety, tolerability and response rate of Acthar in subjects with RRMS who have not responded to high dose intravenous methylprednisolone (IVMP), oral prednisone, or oral methylprednisolone.

Study Description

The purpose of this study is to examine the safety, tolerability and response rate of Acthar in subjects with Relapsing-remitting multiple sclerosis (RRMS) who have not responded to high dose intravenous methylprednisolone, oral prednisone, or oral methylprednisolone.

Additional Information

Participants will be compensated for their participation.


  • IRB Number: 1706802372
  • Research Study Identifier: TX8265
  • Principal Investigator: Jaison Grimes, MD

Recruitment Status

Closed
Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.